Children's Health Defense By
The COVID-19 vaccine inhibits the type-1 interferon pathway — an immune molecule that protects cells against invading pathogens — so mass injecting young children may erase natural herd immunity that would develop if children remained unjabbed.
Story at a glance:
- So far, children have been largely unfazed by COVID-19 because their interferon pathway works really well. Interferon is an immune molecule that protects cells against invading pathogens.
- The COVID-19 jab inhibits the type-1 interferon pathway, so mass injecting young children may actually erase the natural herd immunity against COVID-19 that would develop if all children remained unjabbed.
- Aggressive cancers have exploded among adults who got the shots, even though it’s only been a little over two years since their rollout.
- Analysis of U.S. Morbidity and Mortality Weekly Report data suggests the Centers for Disease Control and Prevention (CDC) is redesignating cancer deaths as COVID-19 deaths to eliminate the cancer signal, and has been doing so since April 2021.
- We’ve also seen massive increases in excess mortality from abnormal clotting issues and heart problems since the COVID-19 shots rolled out. If side effects such as cancer, heart disease and stroke are killing working-age adults in unprecedented numbers already, what will the excess mortality be, say, 10 years from now if children and teens keep getting mRNA boosters every year?
What will the future hold for people whose exposure to COVID-19 occurs during the first years of life? That question was recently asked by Katherine J. Wu, a staff writer at The Atlantic.
Wu writes:
“To be a newborn in the year 2023 — and, almost certainly, every year that follows — means emerging into a world where the coronavirus is ubiquitous … Beyond a shadow of a doubt, this virus will be one of the very first serious pathogens that today’s infants — and all future infants — meet.
“Eventually, the expectation is that the illness will reach a stable nadir, at which point it may truly be ‘another common cold,’ says Rustom Antia, an infectious-disease modeler at Emory.
“The full outcome of this living experiment, though, won’t be clear for decades — well after the billions of people who encountered the coronavirus for the first time in adulthood are long gone.
READ FULL ARTICLE HERE… (childrenshealthdefense.org)
